Leadership Team

Michael Andreini
President and Chief Executive Officer

Stephanie Oestreich, Ph.D., MPA
Managing Director
Scientific Advisory Board

Randi Isaacs, M.D.
Executive Director and Clinical Site Head of Translational Clinical Oncology, Novartis Institutes for Biomedical Research

David R. Parkinson, M.D.
Chairman of the Clinical Advisory Board, Zyngenia, Inc.
Board of Directors

Thomas Conheeney
Retired President, SAC Capital

Dana LaForge
Partner, Brera Capital Partners, LLC

Hugh Martin
President & CEO, Lacuna Technologies Inc.
